Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 413.75 1.31
Hindalco 135.35 0.86
Tata Pow 81.55 3.61
Bhel 175.60 3.17
Ntpc Ltd 122.60 2.27
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Piramal Phytocare Limited
Piramal Phytocare Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:532979NSE:PIRPHYTOBloomberg:PLSL@INReuters:PLSL.BO
Market Lot: 1Face Value: 10ISIN Demat: INE122J01015
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
31-JUL-13 Piramal Life Sciences said its net loss for the quarter ended June 2013 has widened to Rs 15.60. It reported a net loss of Rs 15.40 million in the same quarter last year. 08-MAY-13 Piramal Life Sciences fourth-quarter net loss narrows to Rs 9.7 million for the quarter ended Mar. 31, 2013 as compared to Rs 55.2 million a year ago 01-FEB-13 Piramal Life Sciences offer proprietary medicinal products that are made from standardized herb...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Piramal Life Sciences loss widens in Apr-Jun quarter  -IRIS 31-Jul-13
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2013(9)31-Mar-2013 (12)31-Mar-2012(12)
Net sales 16.3052.4035.70
Other Income1.507.101.60
Total Income17.8059.5037.30
Cost of goods sold20.8076.50632.00
OPBDIT-3.00-17.00-594.70
PAT-37.70-63.60-974.60
Gross Block---
Equity capital259.60259.60259.60
EPS (Rs.)--2.40-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NA-
Debt / Equity (x)---
Operating margin (% of OI)-16.9-28.6-1594.4
Net margin (% of OI)-211.8-106.9-2612.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Piramal Tower Annexe
Ganpatrao Kadam Marg
Lower Parel
Mumbai
Maharashtra-400 013
PHONE
(022) 3046 7837
FAX
(022) 2490 2363
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer